Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Tailoring Zn<sub>2</sub>SnO<sub>4</sub>inverse spinel via Co doping: enhanced two-electron water oxidation for efficient H<sub>2</sub>O<sub>2</sub>electrosynthesis.

Nanotechnology·2026

Same author

Optimization and flavor characterization of milk tea formulated with large-leaf yellow tea and tangerine peel: A combined fuzzy mathematical, response surface, and multimodal sensory approach.

Food chemistry: X·2026

Same author

The first near telomere-to-telomere genome assembly of Panulirus homarus homarus.

Scientific data·2026

Same author

GhZAT10 integrates jasmonic acid and ethylene pathways to synergistically regulate the GhKUP3aD-mediated high-affinity K<sup>+</sup> uptake in Gossypium hirsutum.

Science bulletin·2026

Same author

Extended-field intensity-modulated radiation therapy and high-dose-rate brachytherapy with concurrent chemotherapy for cervical cancer with positive para-aortic or common iliac lymph nodes: a multicenter prospective cohort study.

Journal of gynecologic oncology·2026

Same author

A Comparative Review of Biological, Electrochemical, and Membrane-Based Methods for Direct Ocean Carbon Capture.

Materials (Basel, Switzerland)·2026

Search research articles

Related Experiment Video

Updated: Jun 11, 2025

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Nanoparticle-mediated universal CAR-T therapy.

Mingliang Fan¹, Jiayu Zheng¹, Yue Huang¹

¹School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, China.

International Journal of Pharmaceutics

|September 30, 2024

Summary

This summary is machine-generated.

Universal CAR-T therapy using nanocarriers offers a cost-effective alternative to traditional methods. This approach enables in vivo generation of CAR-T cells, simplifying manufacturing and improving accessibility for cancer immunotherapy.

Keywords:

Gene delivery Lipid nanoparticles Nanoparticle Universal CAR-T therapy

More Related Videos

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Published on: June 14, 2024

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

Related Experiment Videos

Last Updated: Jun 11, 2025

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Published on: June 14, 2024

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

Area of Science:

Immunology
Biotechnology
Nanomedicine

Background:

Chimeric antigen receptor (CAR)-T cell therapy shows success in hematological cancers.
Current CAR-T therapy requires complex, costly, and time-consuming ex vivo manufacturing.
Limited accessibility and high costs hinder widespread adoption of autologous CAR-T treatments.

Purpose of the Study:

To explore nanocarrier-mediated gene delivery for in situ CAR-T cell generation.
To present an "off-the-shelf" universal CAR-T therapy strategy.
To overcome limitations of traditional autologous CAR-T cell manufacturing.

Main Methods:

Utilizing biocompatible nanocarriers for targeted gene delivery.
Developing nanoparticle-mediated in situ generation of CAR-T cells.
Investigating the potential for universal CAR-T therapy.

Main Results:

Nanocarrier delivery of CAR genes enables in vivo CAR-T cell generation.
This strategy significantly simplifies the manufacturing process.
Reduced costs and shortened administration times are anticipated.

Conclusions:

Nanoparticle-mediated in situ CAR-T cell generation is a promising approach for universal CAR-T therapy.
This method offers a cost-effective and accessible alternative to autologous CAR-T manufacturing.
The strategy has the potential to increase the prevalence and efficacy of CAR-T cancer immunotherapy.